CECIP JAÚ - Centro de Estudos Clínicos do Interior Paulista - LTDA

Jaú, São Paulo 17201-130

0 studies enrolling now · 2 studies all time

What they study most

COVID-19

Studies at this site

• EPIC-HR: Study of Oral PF-07321332/Ritonavir Compared With Placebo in Nonhospitalized High Risk Adults With COVID-19 — Completed
• Evaluation of Protease Inhibition for COVID-19 in Standard-Risk Patients (EPIC-SR). — Stopped early